Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Nov 18, 2022
Date Accepted: Apr 17, 2023
Date Submitted to PubMed: Apr 19, 2023

The final, peer-reviewed published version of this preprint can be found here:

Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study

Kim J, Linos E, Fishman DA, Dove MS, Hoch JS, Keegan TH

Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study

JMIR Cancer 2023;9:e44339

DOI: 10.2196/44339

PMID: 37074951

PMCID: 10208306

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Factors Associated with Online Patient-Provider Communications Among Cancer Survivors in the United States during COVID: A Cross-Sectional Study.

  • Jiyeong Kim; 
  • Eleni Linos; 
  • Debra A. Fishman; 
  • Melanie S. Dove; 
  • Jeffrey S. Hoch; 
  • Theresa H. Keegan

ABSTRACT

Background:

Online Patient-Provider Communication (OPPC), using online-based tools, including email/internet, tablets/smartphones, and mobile apps, for patient-provider communication, is crucial in enhancing access to health information, self-care, and related health outcomes among cancer survivors. The necessity of OPPC increased during SARS/COVID-19 (COVID), yet investigations in vulnerable subgroups have been limited.

Objective:

Thus, this study aimed to assess the prevalence of OPPC and sociodemographic and clinical characteristics associated with OPPC among cancer survivors and those without a history of cancer during COVID vs. pre-COVID.

Methods:

Nationally representative cross-sectional survey data (Health Information National Trends Survey, HINTS 5 2017-2020) was used among cancer survivors (n= 2,579) and adults without a history of cancer (n= 13, 292). COVID data was collected from January to June 2020. We calculated the prevalence of three types of OPPC, defined as using email/internet, tablet/smartphone, or Electronic Health Records (EHR) for patient-provider communication, in the past 12 months. To investigate the associations of sociodemographic and clinical factors with OPPC, multivariable-adjusted weighted logistic regression was performed to obtain odds ratios (OR) and 95% confidence intervals (95% CI).

Results:

The average prevalence of OPPC increased from pre-COVID (2017-19) to COVID (2020) among cancer survivors (39.1% vs. 51.3%, email/internet; 29.3% vs. 39.1%, tablet/smartphone; 18.9% vs. 29.9%, EHR). Cancer survivors were more likely to use OPPC than adults without a history of cancer during COVID. During COVID, subgroups of cancer survivors, including racial/ethnic minorities, or those with the low income (OR=3.69, 1.12-12.21 $50,000 to <$75,000 vs. <$20,000), or reporting depression (OR=0.44, 0.20-0.98) were less likely to use email/internet and those who were unmarried (OR=2.44, 1.21-4.91 married vs. unmarried) or had public/no health insurance (vs. private) were less likely to use tablet/smartphone to communicate with providers. Cancer survivors without a usual source of care were significantly less likely to use e-mail/internet (OR=4.77, 1.41-16.18) or EHR (OR=6.63, 1.51-29.06). While not observed in cancer survivors, lower education level and older age were associated with lower OPPC among adults without a history of cancer during COVID.

Conclusions:

Our findings identified subgroups of cancer survivors who were left behind in OPPC, communications which are becoming an increasing part of healthcare. Those vulnerable subgroups of cancer survivors with lower OPPC should be helped through multidimensional interventions to prevent further inequities. Clinical Trial: N/A


 Citation

Please cite as:

Kim J, Linos E, Fishman DA, Dove MS, Hoch JS, Keegan TH

Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study

JMIR Cancer 2023;9:e44339

DOI: 10.2196/44339

PMID: 37074951

PMCID: 10208306

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.